They also reported a case of a 38-year-old patient affected by triple-negative breast cancer, who did not respond to standard therapies and was treated with PSMA-RLT, based on a positive 68Ga-PSMA PET/CT. This evidence concerns the gene FOLH1 and triple-negative breast carcinoma.